| [1] | 惠纪元,龚如,梁玉敏,等. 中国颅脑创伤数据库:短期预后因素分析[J]. 中华神经外科杂志,2014,30(1):56-58. |
| [2] | 江基尧. 中国颅脑创伤研究的现状与未来[J]. 中华医学杂志,2013,93(23):1761-1762. |
| [3] | Stein DG,Wright DW. Progesterone in the clinical treatment of acute traumatic brain injury[J]. Expert Opin Investig Drugs,2010,19(7):847-857. |
| [4] | 王克全,徐寒梅. 多肽类药物的研究进展[J]. 药学进展,2015,39(9):642-650. |
| [5] | Lee EH,Seo SR. Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases[J]. BMB Rep,2014,47(7):369-375. |
| [6] | Katahira M,Yone K,Arishima Y,et al.The neuroprotective effects of PACAP on spinal cord injury (SCI) in rats[J]. Regul Pept,2003,115(1):49. |
| [7] | Reglodi D,Kiss P,Lubics A,et al. Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo[J]. Curr Pharm Des,2011,17(10):962-972. |
| [8] | Farkas O,Tamás A,Zsombok A,et al. Effects of pituitary adenylate cyclase activating polypeptide in a rat model of traumatic brain injury[J]. Regul Pept,2004,123(1-3):69-75. |
| [9] | Vukojevic J,Vrdoljak B,Malekinusic D,et al. The effect of BPC 157 on ischemic/reperfusion injuriesin rat brain[J]. FASEB J,2016,30(1Suppl):705-706. |
| [10] | Tudor M,Jandric I,Marovic A,et al. Traumatic brain injury in mice and pentadecapeptide BPC 157 effect[J]. Regul Pept,2010,160(1-3):26-32. |
| [11] | Tohyama Y,Sikirié P,Diksic M. Effects of pentadecapeptide BPC157 on regional serotonin synthesis in the rat brain:alpha-methyl-L-tryptophan autoradiographic measurements[J]. Life Sci,2004,76(3):345-357. |
| [12] | Amiri-Nikpour MR,Nazarbaqhi S,Ahmadi-Salmasi B,et al. Cerebrolysin effects on neurological outcomes and cerebral blood flow in acute ischemic stroke[J]. Neuropsychiatr Dis Treat,2014,10:2299. |
| [13] | Sharma HS,Zimmermann-Meinzingen S,Johanson CE. Cerebrolysin reduces blood-cerebrospinal fluid barrier permeability change,brain pathology,and functional deficits following traumatic brain injury in the rat[J]. Ann N Y Acad Sci,2010,1199:125-137. |
| [14] | Chen CC,Wei ST,Tsaia SC,et al. Cerebrolysin enhances cognitive recovery of mild traumatic brain injury patients:double-blind,placebo-controlled,randomized study[J]. Br J Neurosurg,2013,27(6):803-807. |
| [15] | álvarez XA,Figueroa J,Muresanu D. Peptidergic drugs for the treatment of traumatic brain injury[J]. Futr Neurol,2013,8(2):175-192. |
| [16] | Faden AI,Fox GB,Fan L,et al. Novel TRH analog improves motor and cognitive recovery after traumatic brain injury in rodents[J]. Am J Physiol,1999,277(4 Pt 2):R1196-R1204. |
| [17] | Jain KK. Neuroprotection in traumatic brain injury[J]. Drug Discov Today, 2008,13(23-24):1082-1089. |
| [18] | Faden AI,Knoblach SM,Cernak I,et al. Novel diketopiperazine enhances motor and cognitive recovery after traumatic brain injury in rats and shows neuroprotection in vitro and in vivo[J].J Cerebr Blood Flow Metabol,2003:342-354. |
| [19] | Faden AI,Movsesyan VA,Knoblach SM,et al. Neuroprotective effects of novel small peptides in vitro and after brain injury[J]. Neuropharmacology,2005,49(3):410-424. |
| [20] | Faden AI,Knoblach SM,Movsesyan VA,et al. Novel small peptides with neuroprotective and nootropic properties[J]. J Alzheimers Dis,2004,6(6 Suppl):S93-S97. |
| [21] | 李淑敏. 促红细胞生成素的临床应用进展[J]. 职业与健康,2013,29(21):2862-2864. |
| [22] | Corwin HL,Gettinger A,Fabian TC,et al. Efficacy and safety of epoetin Alfa in criticallyⅢ patients[J]. New Engl J Med,2007,357(10):965-976. |
| [23] | Collino M,Thiemermann C,Cerami A,et al. Flipping the molecular switch for innate protection and repair of tissues:Long-lasting effects of a non-erythropoietic small peptide engineered from erythropoietin[J]. Pharmacol Ther,2015,151:32-40. |
| [24] | Robertson CS,Cherian L,Shah M,et al. Neuroprotection with an erythropoietin mimetic peptide (pHBSP) in a model of mild traumatic brain injury complicated by hemorrhagic shock[J]. J Neurotr,2012,29(6):1156-1166. |
| [25] | Verghese PB,Castellano JM,Holtzman DM. Apolipoprotein E in Alzheimer's disease and other neurological disorders[J]. Lancet Neurol,2011,10(3):241-252. |
| [26] | Jiang Y,Brody DL. Administration of COG1410 reduces axonal amyloid precursor protein immunoreactivity and microglial activation after controlled cortical impact in mice[J]. J Neurotr,2012,29(13):2332-2341. |
| [27] | Laskowitz DT,Mckenna SE,Song P,et al. COG1410,a novel apolipoprotein E-basedpeptide,improves functional recovery in a murine model of traumatic brain injury[J]. J Neurotr,2007,24(7):1093-1107. |
| [28] | 贺杰,庞金伟,吴越,等. 载脂蛋白E短肽COG1410对蛛网膜下腔出血后早期脑水肿的影响[J]. 第三军医大学学报,2016,38(4):350-355. |
| [29] | Wu Y,Pang J,Peng J,et al. An apoE-derived mimic peptide,COG1410,alleviates early brain injury via reducing apoptosis and neuroinflammation in a mouse model of subarachnoid hemorrhage[J].Neurosci Lett,2016,627:92-99. |